Literature DB >> 8243870

Vasoactive intestinal polypeptide-augmented insulin release: actions on ionic fluxes and electrical activity of mouse islets.

M A Wahl1, S G Straub, H P Ammon.   

Abstract

Vasoactive intestinal polypeptide is a pancreatic neurotransmitter which augments insulin release. To obtain more detailed information on its mode of action on the pancreatic beta cell we studied the effect of vasoactive intestinal polypeptide on 86Rb+ efflux, 45Ca2+ uptake, electrical activity and second messenger systems of isolated mouse islets. Vasoactive intestinal polypeptide enhanced insulin release and 45Ca2+ uptake in a concentration-dependent manner, and was effective at non-stimulatory and stimulatory glucose levels. It increased glucose-induced electrical activity but was without effect on either glucose-mediated changes of 86Rb+ efflux, cAMP or inositol-1,4,5-trisphosphate content. It is suggested that vasoactive intestinal polypeptide augments insulin release by increasing the uptake of Ca2+ into the cell by as yet undefined mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243870     DOI: 10.1007/bf02374473

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Gastrin releasing peptide augments glucose mediated 45Ca2+ uptake, electrical activity, and insulin secretion of mouse pancreatic islets.

Authors:  M A Wahl; R J Plehn; E A Landsbeck; E J Verspohl; H P Ammon
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

2.  Gastrin-releasing peptide: binding and functional studies in mouse pancreatic islets.

Authors:  M A Wahl; E A Landsbeck; H P Ammon; E J Verspohl
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

3.  Effect of W-7 on ionic fluxes and electrical activity of mouse pancreatic islets.

Authors:  M A Wahl; K A Spenny; H Safayhi; H P Ammon
Journal:  Mol Cell Endocrinol       Date:  1990-05-28       Impact factor: 4.102

4.  Membrane potential of beta-cells in pancreatic islets.

Authors:  H P Meissner; H Schmelz
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

5.  Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.

Authors:  S I Said; V Mutt
Journal:  Eur J Biochem       Date:  1972-07-13

6.  Effect of vasoactive intestinal peptide in man.

Authors:  G J Krejs
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

7.  Glucose-induced electrical activity in beta-cells. Feedback control of ATP-sensitive K+ channels by Ca2+? [corrected].

Authors:  J C Henquin
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

8.  Mechanisms of the stimulation of insulin release by oxytocin in normal mouse islets.

Authors:  Z Y Gao; G Drews; J C Henquin
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

9.  Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion.

Authors:  J J Holst; J Fahrenkrug; S Knuhtsen; S L Jensen; S S Poulsen; O V Nielsen
Journal:  Regul Pept       Date:  1984-04

10.  Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves.

Authors:  L I Larsson; J Fahrenkrug; J J Holst; O B Schaffalitzky de Muckadell
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

View more
  1 in total

1.  DBI mRNA is expressed in endocrine pancreas and its post-translational product DBI(33-50) inhibits insulin release.

Authors:  P Borboni; R Magnaterra; O Porzio; A Fusco; G Sesti; A Bertoli; R Lauro; L N Marlier
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.